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Abstract  
Master Thesis, Program in Medicine, 
Title: A follow-up on persons 5 years after subarachnoid hemorrhage  
Author: Lovisa Carlsson 2015 
Institute of Neuroscience and Physiology, Section for Clinical Neuroscience and 
Rehabilitation, Sahlgrenska academy, Gothenburg, Sweden 
 
Background 
Subarachnoid hemorrhage (SAH) has high mortality, high morbidity among survivors, and is 
a major course of long-term disabilities. To develop treatment and rehabilitation for persons 
after SAH, long-term follow-up is needed. Several studies are published on short-term 
outcome with decreased Health-related Quality of Life (HRQoL), mental health and cognitive 
function, though outcome studies >12 months post-SAH are scarce. 
 
Aim 
The aim of this study was investigate physical/emotional status, participation and HRQoL, 
5 years after SAH.   
 
Methods  
The study population were persons living in Gothenburg area, treated at Sahlgrenska 
University hospital after SAH 2009-2010. The study population received by regular mail in 
2014 a questionnaire contained EuroQol-5Dimensions, Stroke Impact Scale, Occupational 
Gaps Questionnaire and Impact of Participation and Autonomy regarding their life 
situation, functioning, participation, and their HRQoL 
 
Results 
The questionnaires was sent to 42 persons where 26 (62%), average age 59, responded, in 
mean 5.1 years post SAH. The persons with SAH in this study had in general lower HRQoL 
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compared to Swedish healthy norm values and particularly lower in the domain of 
anxiety and depression. Twenty-two of the persons with SAH had acceptable 
participation. Half of the study population was independent in their daily life, and 8 of 19 
had returned to work full time. Emotional problems were common and several reported 
problems with fatigue, memory and executive function. 
 
Conclusions 
This long-term follow-up in persons 5 years after a SAH showed in general high level of 
physical function and autonomy, but lower HRQoL and emotional health. Most of the 
persons after SAH had acceptable participation.  
 
Keywords: subarachnoid haemorrhage, outcomes, quality of life, participation 
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Introduction  
Stroke is an umbrella term, and includes cerebral infarction (ischemic stroke), 
intracerebral hemorrhage, intracranial hemorrhage and subarachnoid hemorrhage (SAH) 
(1). Stroke has an overall incidence in the world in persons aged ≥55years  of 4-12/1000 
(2), and is the somatic disease accounts for the largest number of days spent in Swedish 
hospitals, with around 30,000 occurrences yearly in Sweden(3).  
 
The ischemic stroke is the elder person’s disease, and in the high income countries the 
ischemic strokes represent about 85% of all strokes. Despite that, the hemorrhagic 
strokes has a larger effect on global burden (deaths and lost Disability Adjusted Life 
Years) world-wide (4). However, the burden of both stroke types has increased 
significantly the last two decades, both in absolute numbers, deaths, and when counting 
in Disability Adjusted Life Years (4). In addition, predictions indicate that the stroke 
prevalence will increase with about 20 % from 2012 until 2030 due to an aging population 
(5).  
 
SAH is defined as a bleeding in the subarachnoid space, most often (85%) caused by a 
congenital or an acquired, intracerebral aneurysm, that causes weakness in the wall of 
the blood vessels and ruptures. In Sweden about 5% of all strokes are SAH, (3,5). The 
overall incidence of SAH in the world is about 9 per 100´000, with a higher reported 
incidence in Finland and Japan, 15-17 per 100´000 (6). SAH is a diagnosis that effects a 
younger population, with a mean incidence age at 55 years (7 ). Smoking is strongly 
associated with SAH (8), and also use of alcohol and hypertension seems to be risk factors 
(9). Furthermore, women have a 1.4 higher risk to suffer a SAH (10).  
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Subarachnoid hemorrhage (SAH) has a mortality of 30-60% the first month (6,11-13), but 
a larger proportion survive their bleeding every year since the 1970´s (11,12). The 
development of better operation technics and intensive care increase the rate of 
surviving a SAH, and therefore SAH has become a major cause of long-term disability, a 
large economic burden on the societies and causes emotional and economic consequences for 
the patient and their family (14). 
 
According to the Swedish national guidelines (15), the SAH diagnosis should be confirmed 
by CT. If the hemorrhage not is verified by the CT, or when there is high degree of 
suspicion, the CT should be followed by a lumbar puncture within 6 hours after the event. 
The patient with SAH is usually observed and monitored at an intensive care unit or a 
stroke unit, due to the risk of obstruction of their circulation to brain stem, cerebral 
ischemia due to vasospasm and other complications. Possibly aneurysm could be 
confirmed with CT-angiography or conventional angiography and treated with either 
intravascular coiling or neurosurgical clipping, to prevent re-bleeding (6,16). A patient 
treated <72 hours after onset have shown to have a better outcome, and coiling have 
shown  better outcome than clipping (17). To assess the severity of the SAH, the disease-
specific grading scale Hunt & Hess (H&H) could be used (18). The H&H is graded on 
clinical condition ranked from I (no symptoms, mild headache, slight neck stiffness) to V 
(coma, abnormal posturing).  Poor grade patients (H&H grade IV or V) are more often 
treated conservatively since high H&H grade at admission is associated with poor 
outcome (19).  
 
Cognitive impairment, as memory problem or low executive function are limitations 
commonly reported after a SAH (20-22). Even minor deficit in cognition can be a major 
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problem after brain damages in general, and also have a large impact on Quality of life (QoL) 
and life satisfaction (23-27). Even 10 years after SAH, this persons still seems to have 
reduced HRQoL compared to a reference population (28-30) and the emotional health seems 
to influences the HRQoL (31). In a follow-up, 1-10 years after SAH onset, high prevalence of 
impairment in the emotional health were reported (32). A follow- up 2 years after SAH found 
that anxiety and depression were common problems that affected above half of the study 
population (33). 
 
A central goal in rehabilitation is participation. According to the International Classification 
of functioning, Disability and health (ICF), participation is a domain included in the overall 
aspect of health; functioning. Functioning includes body function, body structures and 
activities as well as participation.  Participation is defined as a person´s involvement in a life 
situation, representing the social perspective of functioning (34). Low participation, low 
involvement in a life situation, and inability to return to work effects the QoL (35). It has been 
reported that only a small proportion of persons with SAH returned to full-time work (22), but 
larger studies with longer follow-up are needed. 
 
The prediction of outcome after a SAH is of importance for the patients and their next of 
kin to get right expectations and to encourage the rehabilitation process. Knowledge of 
predictions is also important for the caregivers in order to develop the care and 
rehabilitation. Despite several studies of short-term outcome after SAH, studies >12 
months after onset are scarce. There are also lack of studies including the patients’ 
perspective of their participation and QoL (7,22). 
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Aim 
The aim of this study was to investigate physical/emotional status, participation and HRQoL 5 
years after a SAH.   
Material and methods  
Study population 
This long-term cohort follow-up study,  comprises a study population selected for a cross-
sectional observational study of persons with first occasion of SAH treated at the Neuro 
Surgical Unit and Stroke Unit at Sahlgrenska University Hospital, Sweden, during the 
period 2009-02-04 to 2010-12-02,. The inclusion criteria for the original study were: 1) 
first ever non-traumatic SAH, confirmed by clinical assessment and imaging or lumbar 
puncture, 2) living in the geographical catchment area of the Neuro Surgical Unit or 
Stroke Unit included two other hospitals nearby (within 15 km), hospitals in other parts 
of the region, and one hospital in another region. There was no exclusion by age or other 
medical conditions. The original study population included 141 persons. In the follow-up, 
only persons living in the Gothenburg area were followed, which excluded 86 persons of 
the original population. In addition at the time of follow-up, 13 persons of the original 
population hade died (9 within the first 3 years). 
Data collection procedure 
In the end of 2014, the eligible study population received a self-administrated 
questionnaire by regular mail. The questionnaire included questions regarding the life 
situation, included disease- and non-disease -specific questions and questions on 
different aspects on HRQoL, self-perceived limitations and autonomy. In order to increase 
the response rate, three reminders were sent by mail. When the data were collected, 7 
persons had incomplete questionnaires, and these persons were phoned by the author in 
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order to complete the questionnaires. Additional information from the included persons 
acute hospital (treatment of their SAH) was collected from electronic medical charts.  
 
Questioners  
Life situation 
To explore the person´s life situation, 44 questions based on the Swedish national stroke 
register one-year follow up questionnaire was used. This includes questions regarding 
general health, over all participation, as well as the need of support and social care (36). 
 
 
Health-related quality of life 
The EuroQol-5dimentions (EQ-5D) English version, (Swedish translation) was used to 
assess HRQoL. EQ-5D was established in 1987 of an international group of researchers, 
EuroQol© (37). The EQ-5D has shown to have good validity and reliability (38,39). The 
HRQoL is measured in 5 different dimension; mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. Each dimension is divided into three levels: no 
problem, 1, some or moderate problems, 2, and extreme problems, 3. The answers results 
in a series of number and the five numbers in the different categories are transformed to 
an index with method using a time trade off tariff. As there is no time trade off tariff for 
Sweden, the tariff from the UK (40) were used, which is frequently used in research from 
Sweden. The tariff is transcript into an index score ranges from −1 to 1, (0 (dead) to 1 (full 
health), but with a negative value represent a health condition considered classified worse 
than death) (EQ-5D index). The EQ-5D method also include a visual analogue scale (VAS) 
for individual self-estimating, with endpoints of ‘best imaginable health state’ set at 100 
and ‘worst imaginable health state’ set at 0 (EQ VAS-score). The results of the study 
12 
 
 
population were also compared with results from a large Swedish public health study 
(41). 
 
Stroke impact in daily life   
Stroke impact scale (SIS) version 3.0 (2011) (42), translated to Swedish, was used to 
measure the broad spectrum of stroke recovery and sequels. The SIS is a disease-specific 
scale for stroke shown to have good validity and reliability compared with other 
commonly used stroke scales (43-45). SIS includes 64 questions with five nominal 
categories, assessed in eight domains; four physical; (strength, hand function, ADL/IADL 
and mobility, as well as four emotional domains; communication, emotion, 
memory/thinking, and participation). Mean and a median score in each domain were 
calculated as well as one for the physical index. The formula for calculation was as 
follows: (Mean value of the domain items-1) / (5-1) x 100, which resulted in a score 
between 0-100 where 100 correspond to no problem/full strength in each domain. In 
addition, a self-rating VAS was included in SIS, where the persons estimated their total 
recovery after the stroke, (0 no recovery and 100 full recovery). The results from the 
present study were compared with a Swedish study on persons after stroke (46). In 
addition, to detect limited participation in the study population, a cut-off of 50 were used 
in the participation domain, where below 50 was considered as limited participation (47). 
All above 50 was in the present study were defined as acceptable participation. 
 
Occupational gaps 
Occupational Gaps Questionnaire (OGQ) is an instrument developed in Sweden which has 
previously been used in individuals after acquired brain injury including SAH (48). OGQ 
measures participation using queries on the gaps between what a person want to do and 
actually can do, named “occupational gaps”. OGQ has demonstrated acceptable validity 
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and reliability (49). In addition there seems to be a significant linear regression between 
life satisfaction and occupational gaps (50). The OCQ composes of 30 assertions about 
daily activities with two associated questions, “do you perform the activity?’’ and ‘‘do you 
want to perform the activity? If a person answer either ‘‘yes’’ or ‘‘no’’ to both of the 
associated questions they have no occupational gap. If the answer is ‘‘yes’’ to one 
question and ‘‘no’’ to the other, this is considered to constitute an occupational gap in 
two different types; “does without wanting to do” and the other type is when the person 
“does not, but wants to do” the activity. The both types of occupational gaps are treated 
equally (49). 
 
Participation and Autonomy 
Impact on Participation and Autonomy (IPA), Swedish translation (IPA-S), constructed to 
measures how a disease affects a person’s life. Studies of the original version of IPA 
showed excellent validity and reliability (51-54). The questionnaire includes questions on 
five different aspects; autonomy indoors, family role, autonomy outdoors, social life and 
relationship, and work and educational opportunities. The answers is either; very good 
(0), good, fair, poor, or very poor (4). Median in each domain was calculated when at least 
75% on the items was answered. To identify limited participation the answers “poor” and 
“very poor” were summarized. The results from the present study were visually 
compared with a population after spinal cord injury (SCI) (54). In each domain there is 
also a question that evaluates the person’s experienced problems with participation in 
the actual aspect, with the response options; no problem, minor problems or severe 
problems.  
 
The different questioners can be found in appendices.  
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STROBE Statement 
The STROBE, (Strengthening the Reporting of Observational studies in Epidemiology) 
guidelines (55), is a checklist constructed by epidemiologists, methodologists, 
statisticians, researchers and journal editors to provide guidance on how to report 
observational research well. STROBE provides a checklist on items needed to be included 
when reporting research. This longitudinal cohort study follows the STROBE statement in 
order to ensure the reporting process, see appendices.  
 
Statistics 
For analyze, IBM Statistical Package for Social Sciences (SPSS version 22.0) was used. 
Quantitative method and descriptive statistics were used and presented as mean with 
standard deviation (SD) or median with range where applicable. Independent t-tests and 
χ2-test were used to compare the characteristics of the study population and the persons 
that did not participate. Comparison of differences in results of the study population and 
Swedish healthy norm value or other populations (previously published) were visually 
shown in figures.  
Ethics 
The study was ethical approved by the Regional Ethical Review Board in Gothenburg in 
May 5th 2008 with reference number 225-08 and was completed with additional 
application T 801-10. The part of the study regarding questionnaires was ethical approved 
in June 5th 2013 with reference number 400-13.  
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Results 
Characteristics 
A flow-chart of the inclusion process from the original study (n=141) to this follow-up is 
shown in fig.1. In total the follow-up includes data from 26 persons (study population) 
which represented 62% of the by mailed sent questionnaires. The follow-up period was in 
mean 5.1 years after SAH onset and the main characteristics of the study population are 
presented in table 1. One person of the 26 in the study population reported aphasia and 
submitted an incomplete questionnaire and all the participants did not answer all the 
questions, why the response rate differed (intern drop-out).  
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FIGURE 1 Flow chart of the inclusion process  
 
 
Included at Neuro Surgical Unit 
n=131 
Included at Stroke Unit 
n=10 
Eligible population at time for follow up  
n= 46  
Study population in follow up study 
after 5 years 
n=26  
Not living in the area 
          n=84 
  
Deceased 
n=5 
Deceased 
n=4 
Deceased 
           n=4 
  
Not living in the area 
          n=2 
  
Non-participants n=16; 
No answer n=11 
Decline to participate n=1 
Correct address not found n=2 
Illness due to other reason n=1 
Emigrated n=1 
 
Sent questionnaires        
n=42 
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TABLE 1 Characteristics of the study population (n=26) n % 
Age, years, mean (range) 59,4 (33,0-85,0)    
Women  18 69.0 
Seek help first Sahlgrenska University Hospital 24 92.3 
 Hospital in region/region of Halland 2 7.7 
Treatment Coiling 14 53.8 
 Clipping 3 11.5 
 Coil and stent 1 3.8 
 Conservative/none 8 30.8 
Time at intensive care unit, days 0  3 11.5 
 1-2  5 19.2 
 3-5  5 19.2 
 6-10  3 11.5 
 11-15  3 11.5 
 16-20  4 15.4 
 More than 20  3 11.5 
H&H grade at admission, grade 1 4 15.4 
 2 14 53.8 
 3 2 7.7 
 4 3 11.5 
 5 1 3.8 
 Unknown 2 7.7 
Discharged to Home 10 38.5 
 Rehabilitation unit 12 46.2 
 Other 4 15.4 
Follow-up, years, mean (Range) 5.1 (4.1-5.9)    
Live condition at follow-up Their own homes 25 96.2 
 Nursing home 1 3.8 
Need of daily support at follow-up No need for support 14 53.8 
 None, but there is need 1 3.8 
 Relatives/Partner 7 26.9 
 Social assistance 2 7.7 
 Staff at nursing home 1 3.8 
 Private help/Personal assistance 2 7.7 
H&H, Hunt & Hess: Higher grade represents worse status.  
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Non-participants analysis 
There were no significant difference in treatment method of the SAH, status at admission 
to hospital (H&H) and gender between the study population (n=26) and those who not 
responded the questionnaire (non-participants) (n=16). However, the study population 
were significant older than the non-participants, 59.4 years compared to 46.8 years 
(p=0.001). 
Follow up 
Five years after SAH, 21 out of 26 persons answered the questionnaires themselves. 
Nearly all, except one lived in their own homes, and 12 out of 26 needed daily support 
from others. The question of ability to work was answered as follows, seven persons did 
not work before onset and, six had not returned to work at the time of follow-up. Eight 
persons worked in the same degree as before onset, (42% when counting out of those who 
worked before the SAH). Four persons worked part time (or had a work with less 
responsibility than before onset), and one persons planned to return to work. In addition, 
21/25 had visited or had an appointment with a physician the latest year. Eight out of 24 
reported to have a depressed mood often or always and 7/26 (27%) reported that they 
used antidepressant medication.  
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Health-Related Quality of Life 
Over all this study showed a lower HRQoL in the study population compared to Swedish 
healthy norm values. The self-reported HRQoL using EQ-5D, showed a lower mean in VAS, 
66 compared to the Swedish healthy norm value of 80 (41). In addition, the calculated 
index of the study population was lower 0.67 compared to the reference 0.91. In the study 
population, 10/25 reported to have at least some problems with mobility, few (2/25) 
reported problems with self-care, and one fourth had problems with usual activities. Half 
of the study population reported pain/discomfort and 18/24 reported at least some 
problems with anxiety/depression (Fig. 2). One person described this in words; “the insight 
that I am mortal makes me depressed”.  
 
FIGURE 2 Health- related Quality of Life: Percent scored each level in the five different 
subscales. 
Figure 2 shows the percentage of values in the different domain of the EQ-5D in the study population (n=24) compared to Swedish 
healthy norm value (n=49169). Level 1 indicate no problems, level 2 some problems, and level 3 severe problems. The VAS score 
represent a mean of the study population’s score at their overall health, where higher is the better. The index is calculated from 
the subscales, the mean multiplied with 100, where higher is the better. The study population scores particular lower in the 
subscale Anxiety/Depression and lower in both VAS and index compared to Swedish healthy norm value. 
EQ-5D, EuroQol 5-Dimensions; VAS, Visual Analogue Scale 
*(41) 
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Stroke impact in daily life 
In SIS, the study population showed reduced scores in all domains (table 2). Most 
difficulties were reported in the Emotion domain, with a mean score of 64 out of 
maximum 100. One person wrote; “Focus on the treatment of stroke victims lies on 
physical difficulties. Since I do not have any physical difficulty, I am perceived as a 
healthy person even though my mental health is not entirely good.” Memory, 
Participation, Mobility, The domains Strength and Communication, Hand Function and 
Physical Index had a mean score of 75-79. Persons reported less difficulty in the 
ADL/IADL domain with a total mean of 81. In fig.3 the mean SIS- score in the study 
population was visually compared with persons after stroke (Swedish study, ischemic and 
hemorrhage). Using 50 as a cut-off level in the Participation domain, 4/23 reported 
limited participation. Table 3 shows the individual response to the questions in the four 
persons with limited participation. 
TABLE 2 Calculated Stroke Impact Scale (SIS) score 
Eight domains calculated from SIS, the physical index, a combination between the domain Strength, Hand Function, 
Mobility and ADL, and Stroke Recovery (not calculated). Higher score is the better.  
SIS Domain n Mean SD Median Range 
Strength 24 78 31.0 97 0-100 
Hand function 24 79 32.6 98 0-100 
Mobility 25 77 30.5 94 0-100 
ADL/IADL 26 81 28.0 93 0-100 
Emotion 24 64 18.6 67 22-100 
Memory 24 75 19.7 77 21-100 
Communication 25 78 22.2 86 11-100 
Participation 23 76 21.2 81 25-100 
Physical index 24 76 17.8 81 34-98 
Stroke recovery 25 69 24.5 72 30-100 
SIS, Stroke Impact Scale 
ADL, Activities of Daily Living  
IADL, Instrumental Activities of Daily Living 
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FIGURE 3 Stroke Impact Scale (SIS) -mean score compared to a Swedish population after 
stroke 
Figure 3 shows the SIS score in each domain in the study population (n= 23-26) compared visually with a population 12 month 
after stroke (n=193-204) (46). The study population reports lower scores, compared to the reference stroke population, in the 
emotion, memory and communication domains, but higher in strength and hand function.  
*The response rate varied between 23-26 persons in the study population and 193-204 persons in the stroke population in the 
different subscale 
ADL, Activities of Daily Living.  
 
TABLE 3 Individual follow-up status of those with limited participation (SIS-Participation ≤50) 
ID 
Age at 
onset 
Treatment H&H at 
admission 
Work Participation 
SIS 
Recovery  
SIS 
EQ-5D 
Index 
EQ-5D  
VAS 
Intimacy 
IPA 
GAPS 
8 55 Coiling 3 Not before 44 30 0,656 45 Very poor 1 
10 81 Conservative 1 Not before 25 30 -0,077 35 Very poor 9 
12 55 Coiling 2 Part time 47 75 0,255 50 Very poor Missing 
17 53 Coiling 2 Part time 50 60 0,124 50 Poor 1 
H&H, Hunt&Hess. SIS, Stroke Impact Scale. EQ-5DEuroQol 5Dimensions.  VAS, Visual Analogue Scale. IPA, Impact of Participation. 
GAPS, occupational gaps of daily life according to Occupational Gaps Questionnaire.  
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Occupational gaps 
Over all, the study population, 9 out of 24 reported no occupational gaps in daily life. 
Table 4 showed the distribution of the gaps, which was widely spread both in and 
between the different domains. The number of gaps reported in the study population 
ranged from 0- 15 out of total 30 possible gaps. Most numbers of incongruence will, but 
cannot, was found in Outdoor life and Hobbies, where 5/24 had gaps, see table 5. The gaps 
in performing activities despite not want to was presented in table 6, where 3/24 could, 
but did not want to do; Administering economy, cleaning and/or shopping clothes. 
Experience of occupational in daily life described in the comment field, there were 
answers like “my problem is not that I have lost the ability, but I lack the ability to get 
started and make initiative”, “I experience a major fatigue after social activities like 
cinemas, parties, trips. Especially when there are a lot of people” “I miss control of my 
life, and let it passively run out. I lack energy, ability to take initiative and I suffer from 
fatigue” “I love to dance but it doesn´t work. High volume and I gets dizzy and tired”.   
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TABLE 4 Distribution of occupational gaps. 
Gaps describes differences between what the person wants to do, and actually can do. Performing represent what 
the person does, and the different Gaps represent how many in the population that either do not can or do not 
want. 
(n=24) Performing  
 
 
(%) 
Do not 
want to  
 
(%) 
Gap; want to, 
but can not 
(n) 
Gap; do not 
want to, but 
can  
(n) 
     
Instrumental-ADL     
Shopping (groceries) 92 8 1 1 
Cooking 79 13 2 
 Washing clothes 75 25 1 1 
Cleaning 75 38 
 
3 
Light maintenance (home, garden, car) 58 33 3 1 
Heavy-duty maintenance 29 63 3 1 
Administering economy 88 25 
 
3 
Transportation 79 13 2 
 Leisure activities 
    Shopping (clothes) 83 17 3 3 
Sports 67 17 4 
 Outdoor life 63 21 5 1 
Hobbies 58 21 5 
 Cultural activities 79 21 1 1 
TV/video/radio 96 4 
  Reading newspaper 88 4 2 
 Reading periodicals/literature 75 8 4 
 Writing 38 50 4 1 
Games, pools, crossword 63 21 4 
 Computer games & surfing the Internet 92 13 
 
1 
Social activities 
    Seeing partner and children* 91 0 2 
 Seeing relatives, friends & neighbours 88 4 2 
 Support others (babysitting) 58 29 3 
 Activities in societies, clubs or unions 33 54 4 1 
Religious activities 4 96 
  Visiting restaurants and bars 79 17 1 
 Travelling for pleasure 75 17 4 2 
Work or work-related activities 
    Working full or part-time 46 54 1 1 
Studying full or part-time 4 88 2 
 Taking care of and raising children 8 83 2 
 Voluntary work 13 75 3 
 *n=23 
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TABLE 6 Occupational Gaps Questionnaire (OGQ)  
- GAPS; can, but will not, responded by at least three persons 
 (n=24) 
Items n % 
Administering economy 3 13 
Cleaning 3 13 
Shopping (clothes) 3 13 
 
 
  
TABLE 5 Occupational Gaps Questionnaire (OGQ)  
- Gaps; will but cannot, responded by at least three persons 
(n=24) 
 
Items n % 
Outdoor life 5 21 
Hobbies 5 21 
Writing 4 17 
Travelling for pleasure 4 17 
Sports 4 17 
Reading periodicals/literature 4 17 
Games, pools, crossword 4 17 
Activities in societies, clubs or unions 4 17 
Voluntary work 3 13 
Support others (babysitting) 3 13 
Shopping (clothes) 3 13 
Light maintenance (home, garden, car) 3 13 
Heavy-duty maintenance 3 13 
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Impact of participation and autonomy 
Over all, the majority of the study population reported good or very good participation 
assessed with the IPA-E. Highest median was shown in the domain of Autonomy Indoors 
where 18 out of 25 reported very good participation (table 7). When the answers “poor” 
and “very poor” are summarized in each of the five domains, this was most frequently 
reported in  the domains Work and Education, Social Life/Relations and Family role, and 
was in addition  compared visually with persons after SCI where lower participation in 
the study population where seen in work and education (table 8). In the items of 
opportunity for intimacy (question 6f in the domain social life), 9/25 reported “poor” or 
“very poor” autonomy. Other questions regarded problem experience was presented in  
fig. 4; there was 3/25 who reported no problem in all of the 8 aspects of participation, and 
on the other hand 7/25 reported major problems in ≥1 of the aspects. The remaining 15 
had mean 3.2 (1- 5) aspects with minor problems.  
TABLE 7 IPA - Distribution of the calculated median score in each subscale (n) 
IPA subscales n Very good Good Fair Poor Very Poor 
Autonomy Indoors 25 18 3 3 0 1 
Family Role 24 10 6 3 4 1 
Autonomy Outdoors 25 9 7 4 3 2 
Social Life and Relationships 25 6 10 7 2 0 
Work and Education 13 2 3 4 2 2 
IPA, Impact of Participation and Autonomy 
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TABLE 8 IPA - Reports of limited participation (%) 
Reports of insufficient (poor or very poor) participation, compared with a population after Spinal Cord Injury (SCI) (54). Higher number 
indicates more restrictions in participation, and 0 indicates no insufficient participation in any of the items in the 5 domains. 
Items in each domain 0 1 - 2 3 - 4 ≥5 
  
  n 
Study % SCI  
% 
Study 
% 
SCI 
% 
Study 
% 
SCI 
% 
Study 
% 
SCI 
% 
Domains of IPA          
Autonomy indoors (7 items) 25/157 88 67 8 17 0 10 4 7 
Family role (7 items) 24/151 58 39 13 23 21 17 8 20 
Autonomy outdoors (5 items) 25/156 72 44 8 24 16 24 4 8 
Social relations (6 items) 25/155 60 58 24 31 12 7 4 1 
Work and education* (6 items)  13/74 31 57 31 23 15 14 23 6 
*Some persons in the study population reported that these items were not relevant, and in accordance with the instructions they did not 
respond to these items. 
IPA, Impact of Participation and Autonomy. 
 
 
FIGURE 4 Problem experiences in different aspects of participation 
Percent reported each level of problems in the different aspects of participation using IPA. (n=25 in Mobility, Self-Care, Leisure, 
Social Life and Relationship, n=24 in Family Role and Financial Situation, n=13 in Work, n=9 in Education.) 
IPA, Impact of Participation and Autonomy. 
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Discussion 
The primary findings of this study were that SAH had large impact on HRQoL, on 
participation and on working capacity. Five years after a SAH, the majority of the persons 
was independent and had relatively good physical function. Contrary, their mental health was 
in general low, with anxiety and depression frequently reported, and antidepressant 
medication were commonly used. 
 
The measured QoL in person with SAH after 5 years were more reduced compared to 
Swedish healthy norm value in four out of five domains, as well as the persons with SAH 
reported more severe problems. The low HRQoL after SAH are consistent to earlier studies of 
short-term outcome (28,56,57) as well as in QoL >5 years after SAH (29,58). In a follow-up 
after 12.5 years, improvement in QoL between the assessments (5 to 12.5 years) was shown 
(58). These findings could indicate that the lower HRQoL found in the present study does not 
need to be life-long. Four persons in the present study had reduced participation, and they had 
in addition reduced QoL. The present study showed a high risk of having mental problems 
and lower QoL many years after SAH. This stress the importance of health professionals 
should be aware of these problems and in an early stage identify, treat, and give correct 
information to persons with SAH. Future follow-up studies >5 years after SAH onset could 
increase the knowledge of the QoL as well as the participation in a longitudinal perspective 
and could be focused on identify  factors that induce good recovery and increase the QoL in 
persons after SAH. 
 
High levels of anxiety and depression in EQ-5D as well as decreased score in the emotion 
domain of SIS were shown in the present study. Mood disorders have been shown to be 
common in persons after all types of strokes related to diffuse brain damages (67, 68), and 
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mental problems such as depression and post-traumatic stress disorder could be 
associated with SAH. The depression has been suggested to be related to the hemorrhage 
(the brain damage itself), as well as to the experience of sudden illness with dramatic 
course (24, 65, 66). Even if this follow-up is five years after the SAH onset, emotion scores 
were lower than in another population one year after a stroke (61). In addition, the 
present study reported increased problems not visible for others like emotionally 
problems, memory difficulties and communication disorders. This is in contrast to after a 
stroke, where deficits more obvious for acquainted is more commonly reported as 
reduced strength, reduced hand function and reduced ADL capacity (43,46,59). This 
exemplifies the importance to identify individual and not general system in the 
rehabilitation process such as different focus in physical training and development of 
coping strategies.  It is reasonable to be aware of the high prevalence for mental illness 
and screen for this in all persons treated after SAH both in an early stage and at 
neurosurgical follow-up.  
 
Despite the general good physical status in the study population, more than half of the 
persons reported they had not returned to previous levels of employment at follow up. 
Among the persons who were employed before, 42% were back at previous occupation in 
the same levels as before, a number concordant to earlier large studies (7,22,60). The high 
mean age in the present population could affect the number of persons returning to 
work. As mention, suffering from fatigue, impairment in cognitive functions, changed 
behavior and personality could be common after acquired brain injury, including SAH 
(58,61,62). As these symptoms were frequently reported this could be a limiting factor 
from being able to return to work after the SAH (23,63-65). The visual comparison with 
the population after SCI (54) aimed to find similarities and differences with a condition 
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that do not affect the brain. A brain damage generally causes mental symptoms as fatigue 
and tiredness and in this report we thought it was important to visually show what 
impact this might have on the population. Participation at work and education seems to 
be lower in this study population with diffuse brain damages compared to physical 
impairments which social insurance system need to be aware of.  An earlier study after 
brain damages including SAH found significant changes in outcome between six month – 
one year and suggested follow-up more than one year after onset (27). The present study 
suggest an additional follow-up up to five years after SAH to offer support with the 
problems that persons commonly have reported.  
 
The four persons who had reduced participation in SIS, reported in addition very low QoL 
in the EQ-5D VAS, all below 50. But no evident connection were seen between low QoL and 
many occupational gaps according to OGQ , among the four persons with limited 
participation, two individuals had 1 gap, one had 9 gaps, and one was missing. The 
present study showed that number of gaps in the OGQ could vary between persons 
independent of level of participation and QoL.  
 
In OGQ, 9 persons (38%) reported no gaps, and that could indicate slightly better result 
than an earlier study on persons after acquired brain injury (48).  It can also indicate a 
degree of acceptance of the study population’s situation after 5 years, to no longer have a 
desire to do the thing that they cannot do. It was shown in the assembly of different gaps 
with a wide distribution and this might indicate problems in all aspect of occupational in 
the everyday life. The wide variations could be related to circumstances not related to the 
SAH, as personal interests, economic and social factors. Despite that, OGQ might be useful 
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to detect a person´s preference when discussing expectations of recovery and choosing 
activities in a rehabilitation situation.  
 
The choice of method for data collection in this study was questionnaires by regular mail. 
This was selected due to this in general is time- and cost-saving compared from 
interviews or an objective assessment. Participants can respond to the questions where 
and whenever they want and do not need to come to a special assessment.. Moreover, 
questionnaires were easily analyzed, and the risk of for example interview bias was 
reduced. In contribution, a respondent’s opinion and experiences is in this method used 
as the truth. A limitation with standardized questioners could be thelimited flexibility. It 
is difficult to extend and vary the questions when it is needed and no follow-up issues 
could be asked (as in an interview). Questioners used in the present study included 
comment fields used as supplements for enhance the answers.  The questionnaire 
included 40-pages and five different evaluation tools, and it could be likely to believe that 
this amount could reduce the participation. To make the participation more attractive 
and eventually reach a higher response-rate a special designed questioner designed for 
persons with SAH could have been used. In lack of such questioner we chose to use a 
combination of different evaluation tools to cover the aim of the study. Moreover, 
another limitation when mailing questionnaires could be that the response-rate in 
questionnaires could decrease, though it seems to increase when sending by regular mail 
compared to e-mail. Furthermore, questions in the questioners were not always clear 
formulated and it was sometimes difficult to determine if the respondent has really 
understood the question. As has been noted, persons with low grade of education or 
reading difficulties might find it complicated to fill the questioners, and consequently not 
respond. An idea to increase response-rate is to offer help to fill in the questionnaire for 
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those who wished which not was made in the present study. Acquiescence bias, in other 
words not understanding the questions correct, could also be a risk that could have been 
avoided with support in the completion part. Additional problems with questionnaire 
could be that persons that have an interest in the subject may be more likely to respond. 
Another possibility of bias could be that respondents may have misunderstood questions 
because no answer completely fitted the respondent.  
 
Although the study population lived in the area of Gothenburg and were treated and 
followed-up at the same Neuro Surgical Unit, different municipalities and community 
health centres were responsible for further support and care which could have influenced 
the results in this study.   
 
Descriptive statistics were used due to the limited sample size of the study population. 
The sample size is small, but the study covers a well-defined geographical area of a 
relative infrequently disease with high mortality. After three reminders, 38% did not 
respond, which could be seen as acceptable for a period about five years after SAH onset. 
However, the possibility of attrition bias cannot be ruled out, even though the non-
participants did not differ significantly from the study population except from a younger 
age. Younger persons generally have a lower response rate in surveys (66,67), which 
could have affect the results in both ways. Naturally, older people could have a general 
lower health that could reflect the results, but a younger population could report lower 
QoL due to limitations compared to people in their own age. Moreover, there was intern 
drop-out in the questionnaires, one due to aphasia and in addition one to two persons in 
the various questionnaires. Another limitation was lack of assessment of neuro 
psychological functions, though earlier studies have showed that neuropsychological 
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factors could play an important role in the rehabilitation after SAH, and seems to have a 
large influence on HRQoL (68).  
Conclusions and implications  
This follow-up describes acceptable level of QoL and functioning in persons five years 
after SAH onset. Five years after onset, persons with SAH in general reported reduced 
HRQoL, emotional health, participation and return to work. Persons with SAH seem to 
have more problems with hidden disabilities compared to other types of stroke. The 
current transition to value-based healthcare, where the caregiver are responsible for all 
care a certain disease requires, makes long-term follow-ups even more important. 
Commonly used as outcome measures after SAH are modified Rankin Scale and Glasgow 
Outcome Scale but there is a need of more influence of quality-of-life benefit and self-
perceived health besides surgical success and physical recovery. By adding instrument for 
evaluation of QoL and participation at the follow-ups, important information of persons 
with SAH use full in improvements of the care.  
This findings needs to take into account when organizing both the acute and the 
rehabilitation phases of persons after SAH and can in addition help care-givers to give 
relevant expectation of the treatment and rehabilitation process.  
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Populärvetenskaplig sammanfattning 
 
5-årsuppföljning av personer vårdade efter subarachnoidalblödning  
 
Författare: Lovisa Carlsson 
Handledare: Katharina Stibrant Sunnerhagen 
Bihandledare: Hanna Persson 
 
Stroke som innefattar både hjärninfarkt (propp i hjärnan) och blödning är en mycket 
vanlig sjukdom i hela världen. Omkring 30´000 personer insjuknar i Sverige årligen. Av 
alla stroke i Sverige är ca 5 % subarachnoidalblödningar (SAB). Blödningen orsakar ett 
allvarligt tillstånd med hög dödlighet. Vanligaste orsaken till SAB är ett artärbråck i 
hjärnan som brustit vilket kan åtgärdas neurokirurgiskt om man hittar det i tid.  
 
Man tror att SAB kommer att öka med den åldrande befolkningen, dessutom har vården 
för personer med SAB förbättrats de senaste 30 åren vilket leder till att fler överlever. 
Följder och konsekvenser av en SAB kan bli stor med en starkt försämrad livskvalitét. Få 
långtidsuppföljningar av personer som drabbats av SAB har gjorts. Syftet med denna 
studie var att undersöka personer som insjuknat i SAB, deras hälsorelaterade livskvalité, 
möjlighet till delaktighet i samhälle och med familj samt undersöka hur de mår fysiskt 
och psykiskt fem år efter insjuknade.  
 
Femtiofem personer som insjuknat med SAB och vårdats vid Sahlgrenska 
Universitetssjukhuset under perioden 2009-2010, samt var boende i Göteborgsområdet 
ingick i studien. Fem år efter insjuknade var 42 personer i livet, och dessa fick ett 
frågeformulär per post med frågor om hälsotillstånd och behov av stöd och hjälpinsatser, 
hälsorelaterad livskvalité, delaktighet i samhälle och familj, fysisk och psykisk 
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funktionsförmåga samt självbestämmande. Typ av vård och behandling i samband med 
insjuknandet i SAB undersöktes också.  
 
Fem år efter SAB hade personerna lägre livskvalitet jämfört med svenskar i samma ålder. 
De hade också mer oro och depressiva problem. Många använde antidepressiv medicin 
och flera hade inte kommit tillbaka till sitt tidigare arbete. Man beskrev besvär med 
hjärntrötthet, nedsatt initiativförmåga och andra problem som inte omgivningen kunde 
se, detta påverkade deras relationer och möten med andra. Dessa dolda funktionhinder 
upplevs många gånger som det största problemet och verkar skilja sig jämfört med 
personer som haft annan typ av stroke där fysiska svårigheter verkar vara dominerande. 
Några personer rapporterade sämre delaktighet i samhälle och familj, dessa hade också 
en mycket nedsatt livskvalitet. Delaktighet jämfördes med personer som haft en 
ryggmärgsskada, där man ser stora fysiska nedsättningar men inte någon påverkan på 
hjärnan, det visade mer svårigheter inom arbete och studier hos de som drabbats av SAB 
än de som fått en ryggmärgsskada.  
 
Sammanfattningsvis kan man säga att fem år efter SAB har många personer problem med 
oro, depressiva besvär och nedsatt livskvalité. Behov av uppföljning och extra stöd kan 
finnas i många år efter insjuknade. Att vårdpersonal blir medvetna om detta är viktigt, 
för att man i tidigt skede ska kunna fånga upp, behandla, och informera kring problemen. 
Att delaktighet och återgång i arbete är begränsad även fem år efter insjuknande, kan 
betyda att dessa personer kan behöva hjälp att med att hitta strategier för att hantera sin 
nya livssituation.  
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Appendices 
Hunt & Hess grade  
 
1.  Asymptomatic, or minimal headache and slight nuchal rigidity 
2.  Moderate to severe headache, nuchal rigidity, no neurologic deficit other than cranial nerve palsy 
3.  Drowsiness, confusion, or mild focal neurologic deficit 
4.  Stupor, moderate to severe hemiparesis, possibly early decerebrate rigidity and vegetative disturbance 
5.  Deep coma, decerebrate rigidity, moribund appearance 
(18) 
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STROBE Statement 
 
Checklist of items that should be included in reports of cohort studies  
 Item 
No Recommendation Present study 
 Title and abstract 1 (a) Indicate the study’s design with a commonly 
used term in the title or the abstract 
Yes persons indicate cohort 
(b) Provide in the abstract an informative and 
balanced summary of what was done and what 
was found 
Yes 
Introduction  
Background/rationale 2 Explain the scientific background and rationale 
for the investigation being reported 
Yes  
Objectives 3 State specific objectives, including any 
prespecified hypotheses 
Yes  
Methods  
Study design 4 Present key elements of study design early in 
the paper 
Yes  
Setting 5 Describe the setting, locations, and relevant 
dates, including periods of recruitment, 
exposure, follow-up, and data collection 
Yes  
Participants 6 (a) Give the eligibility criteria, and the sources 
and methods of selection of participants. 
Describe methods of follow-up 
Yes 
(b) For matched studies, give matching criteria 
and number of exposed and unexposed 
Not applicable 
Variables 7 Clearly define all outcomes, exposures, 
predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if applicable 
Diagnostic criteria according to 
Swedish guidelines.. Exclusion 
criteria  
Data sources/ 
measurement 
8*  For each variable of interest, give sources of 
data and details of methods of assessment 
(measurement). Describe comparability of 
assessment methods if there is more than one 
group 
Yes, the evaluation tools  
 Only one group 
Bias 9 Describe any efforts to address potential sources 
of bias 
Prospective data collection  
The same living area. 
 
Study size 10 Explain how the study size was arrived at 1,5 years inclusion. Administration 
breaks. 3 reminders, telephone.  
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Quantitative 
variables 
11 Explain how quantitative variables were handled in the 
analyses. If applicable, describe which groupings were chosen 
and why 
One group 
Statistical 
methods 
12 (a) Describe all statistical methods, including those used to 
control for confounding 
Descriptive data. No control for 
confounding 
(b) Describe any methods used to examine subgroups and 
interactions 
Not applicable 
(c) Explain how missing data were addressed =n in each tool. >75% in each 
subscale.  
(d) If applicable, explain how loss to follow-up was addressed Nonparticipants analysis 
(e) Describe any sensitivity analyses Validated evaluation tools 
were used 
Results  
Participants 13* (a) Report numbers of individuals at each stage of study—eg 
numbers potentially eligible, examined for eligibility, confirmed 
eligible, included in the study, completing follow-up, and 
analysed 
Yes, flow chart  
(b) Give reasons for non-participation at each stage Yes, flow chart  
(c) Consider use of a flow diagram Yes, flow chart  
Descriptive 
data 
14* (a) Give characteristics of study participants (eg demographic, 
clinical, social) and information on exposures and potential 
confounders 
Table 1  
(b) Indicate number of participants with missing data for each 
variable of interest 
In tables and results.  
(c) Summarise follow-up time (eg, average and total amount) Yes, range and mean in table 
1.  
Outcome data 15* Report numbers of outcome events or summary measures over 
time 
All included are identified in 
the outcome 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-
adjusted estimates and their precision (eg, 95% confidence 
interval). Make clear which confounders were adjusted for and 
why they were included 
Not applicable 
(b) Report category boundaries when continuous variables were 
categorized 
Not applicable 
(c) If relevant, consider translating estimates of relative risk into 
absolute risk for a meaningful time period 
Not applicable 
Other analyses 17 Report other analyses done—eg analyses of subgroups and 
interactions, and sensitivity analyses 
Not applicable 
Discussion  
Key results 18 Summarise key results with reference to study objectives Qolref 
Anxiety/deprref 
Participationref 
Cognref 
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Limitations 19 Discuss limitations of the study, taking into account sources of 
potential bias or imprecision. Discuss both direction and 
magnitude of any potential bias 
Study pop, response, age, 
education, living 
Interpretation 20 Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity of analyses, results from 
similar studies, and other relevant evidence 
Yes 
Generalisability 21 Discuss the generalisability (external validity) of the study 
results 
Yes 
Other information  
Funding 22 Give the source of funding and the role of the funders for the 
present study and, if applicable, for the original study on which 
the present article is based 
 
 
*Give information separately for exposed and unexposed groups. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published 
examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web 
sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology 
at http://www.epidem.com/). Information on the STROBE Initiative is available at http://www.strobe-statement.org. 
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